• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?

作者信息

Kappers-Klunne M C, van Asten J G, van Vliet H H

出版信息

Ann Hematol. 2009 Oct;88(10):1025-8. doi: 10.1007/s00277-009-0709-7. Epub 2009 Feb 11.

DOI:10.1007/s00277-009-0709-7
PMID:19205653
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2728906/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7543/2728906/3f8bb28629fc/277_2009_709_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7543/2728906/3f8bb28629fc/277_2009_709_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7543/2728906/3f8bb28629fc/277_2009_709_Fig1_HTML.jpg

相似文献

1
ADAMTS-13 and Von Willebrand factor in relation to platelet response during plasma exchange in thrombotic thrombocytopenic purpura: a clue for disease mechanism?血栓性血小板减少性紫癜血浆置换过程中ADAMTS-13和血管性血友病因子与血小板反应的关系：疾病机制的线索？
Ann Hematol. 2009 Oct;88(10):1025-8. doi: 10.1007/s00277-009-0709-7. Epub 2009 Feb 11.
2
[Recent therapeutic strategy for thrombotic thrombocytopenic purpura].[血栓性血小板减少性紫癜的最新治疗策略]
Rinsho Ketsueki. 2014 Jan;55(1):93-104.
3
Thrombotic thrombocytopenic purpura in childhood.儿童血栓性血小板减少性紫癜
Pediatr Blood Cancer. 2009 Oct;53(4):537-42. doi: 10.1002/pbc.22094.
4
Deficiency of ADAMTS13 in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜中ADAMTS13的缺乏
Int J Hematol. 2002 Aug;76 Suppl 2:132-8.
5
The pathogenicity of von Willebrand factor in thrombotic thrombocytopenic purpura: reconsideration of treatment with cryopoor plasma.血管性血友病因子在血栓性血小板减少性紫癜中的致病性：对冷沉淀贫血浆治疗的重新思考。
Transfusion. 2006 Jan;46(1):74-9. doi: 10.1111/j.1537-2995.2005.00674.x.
6
[TTP/HUS and VWF/ADAMTS-13].[血栓性血小板减少性紫癜/溶血尿毒综合征与血管性血友病因子/含凝血酶敏感蛋白基元的去整合素样金属蛋白酶13]
Rinsho Ketsueki. 2003 Dec;44(12):1144-53.
7
Platelet activation and the formation of the platelet plug: deficiency of ADAMTS13 causes thrombotic thrombocytopenic purpura.血小板活化与血小板凝块的形成：ADAMTS13缺乏导致血栓性血小板减少性紫癜。
Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):388-96. doi: 10.1161/01.ATV.0000058401.34021.D4. Epub 2003 Jan 30.
8
[Treatment of thrombotic thrombocytopenic purpura].[血栓性血小板减少性紫癜的治疗]
Rinsho Ketsueki. 2014 Oct;55(10):2076-86.
9
Clinical usefulness of a functional assay for the von Willebrand factor cleaving protease (ADAMTS 13) and its inhibitor in a patient with thrombotic thrombocytopenic purpura.血管性血友病因子裂解蛋白酶（ADAMTS 13）及其抑制剂功能检测在一名血栓性血小板减少性紫癜患者中的临床应用价值
Am J Hematol. 2004 Feb;75(2):96-100. doi: 10.1002/ajh.10457.
10
[The Cutting-edge of Medicine: Pathophysiology and Management of thrombotic thrombocytopenic purpura].《医学前沿：血栓性血小板减少性紫癜的病理生理学与管理》
Nihon Naika Gakkai Zasshi. 2015 Mar 10;104(3):607-14. doi: 10.2169/naika.104.607.

引用本文的文献

1
A Long-Term Follow-Up Study in Immune-Mediated Thrombotic Thrombocytopenic Purpura: What Are the Outcomes?免疫介导性血栓性血小板减少性紫癜的长期随访研究：结果如何？
J Clin Med. 2023 Nov 25;12(23):7305. doi: 10.3390/jcm12237305.
2
ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies.ADAMTS - 13在血栓性微血管病诊断与治疗中的应用
Rambam Maimonides Med J. 2014 Oct 29;5(4):e0026. doi: 10.5041/RMMJ.10160. eCollection 2014 Oct.

本文引用的文献

1
Thrombotic thrombocytopenic purpura in humans and mice.人类和小鼠中的血栓性血小板减少性紫癜。
Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1901-8. doi: 10.1161/ATVBAHA.107.145797. Epub 2007 May 24.
2
Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood.在流动血液中，ADAMTS13对血管性血友病因子介导的血小板血栓的大小调节作用
Blood. 2006 Mar 1;107(5):1943-50. doi: 10.1182/blood-2005-07-2972. Epub 2005 Nov 17.
3
Platelet-derived VWF-cleaving metalloprotease ADAMTS-13.血小板衍生的血管性血友病因子裂解金属蛋白酶ADAMTS-13
J Thromb Haemost. 2005 Nov;3(11):2536-44. doi: 10.1111/j.1538-7836.2005.01561.x. Epub 2005 Sep 13.
4
Thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜
J Thromb Haemost. 2005 Aug;3(8):1663-75. doi: 10.1111/j.1538-7836.2005.01425.x.
5
Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets.人血小板中血管性血友病因子裂解蛋白酶（ADAMTS-13）的检测
Biochem Biophys Res Commun. 2004 Jan 2;313(1):212-6. doi: 10.1016/j.bbrc.2003.11.111.
6
ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.ADAMTS-13在流动条件下能迅速切割内皮表面新分泌的超大血管性血友病因子多聚体。
Blood. 2002 Dec 1;100(12):4033-9. doi: 10.1182/blood-2002-05-1401. Epub 2002 Jul 25.
7
Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura.血管性血友病因子裂解蛋白酶活性降低并不局限于血栓性血小板减少性紫癜患者。
Br J Haematol. 2001 Mar;112(4):1087-8. doi: 10.1046/j.1365-2141.2001.02622-5.x.
8
Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).基于降解的血管性血友病因子（vWF）胶原结合亲和力降低的vWF裂解蛋白酶检测：一种用于诊断血栓性血小板减少性紫癜（TTP）的工具。
Thromb Haemost. 1999 Nov;82(5):1386-9.
9
Triplet structure of human von Willebrand factor.人血管性血友病因子的三联体结构
Biochem J. 1998 Apr 15;331 ( Pt 2)(Pt 2):483-8. doi: 10.1042/bj3310483.
10
Enzyme immunoassay for factor VIII-related antigen.因子VIII相关抗原的酶免疫测定法。
Clin Chem. 1982 Jun;28(6):1356-8.